Core Insights - Green Thumb Industries reported record fourth-quarter revenue of $311 million, a 5.7% increase year-over-year, and full-year revenue of $1.2 billion, up 3.4% despite price compression [5][10][14]. Financial Performance - Fourth-quarter revenue was $311.1 million, with a normalized EBITDA of $100.2 million, representing 32.2% of revenue [10][21]. - Full-year revenue reached $1.2 billion, with normalized EBITDA of $348.4 million, or 29.6% of revenue [10][21]. - GAAP net income for the fourth quarter was $83.2 million, or $0.36 per basic share, and for the full year, it was $114.2 million, or $0.49 per basic share [10][20]. Operational Highlights - The company expanded its retail footprint by 12 locations, totaling 113 stores across 14 states [11]. - The launch of adult-use cannabis in Minnesota contributed significantly to fourth-quarter performance [14][15]. - RYTHM was the top flower brand in the U.S., with its Animal Face strain being the best-selling flower unit in 2025 [7]. Capital Allocation and Shareholder Returns - The company repurchased approximately 15.5 million subordinate voting shares for $121.8 million since September 2023 [12][26]. - A $50 million increase to the existing credit facility was made, enhancing financial flexibility [5][23]. Market Position and Strategy - Green Thumb's strategy focuses on operational efficiencies and brand equity, with initiatives like the RYTHM Bud Ball concert series engaging over 4,000 attendees [6][8]. - The company aims to capitalize on evolving regulatory frameworks and growing consumer demand for THC products through strategic investments [13].

Core Viewpoint - Green Thumb Industries Inc. has increased its syndicated credit facility by $50 million, totaling $189 million, to support general corporate purposes and potential strategic investments [1][2]. Group 1: Financial Details - The credit facility is led by Valley National Bank and has a maturity date of September 11, 2029, with an interest rate of Secured Overnight Financing Rate (SOFR) + 500 basis points [2]. - The additional funds will be utilized for general corporate purposes, potential strategic investments, and other working capital requirements [1]. Group 2: Company Overview - Green Thumb Industries is a leading national cannabis consumer packaged goods company headquartered in Chicago, Illinois, operating RISE Dispensaries [3]. - The company manufactures and distributes a portfolio of licensed, branded cannabis products and serves millions of patients and customers annually [3]. - Established in 2014, Green Thumb operates 20 manufacturing facilities and over 100 retail stores across 14 U.S. markets, employing approximately 5,000 people [3].

Industry Overview - The U.S. cannabis sector is transitioning towards a more disciplined approach, prioritizing profitability over rapid expansion, leading to a separation between stronger and weaker companies [1][2] - State-level legalization is expanding, and existing markets are becoming more efficient and competitive, with steady consumer demand despite economic uncertainty [2] - Investors are focusing on companies with scale, strong brands, and operational efficiency as the industry evolves [2][3] Company Highlights Green Thumb Industries (GTBIF) - Green Thumb Industries is recognized as one of the most disciplined cannabis operators in the U.S., balancing retail operations with branded wholesale distribution for revenue stability [3][4] - The company operates numerous retail dispensaries under the Rise brand and has a strong presence in states like Illinois, Pennsylvania, Florida, New Jersey, and Nevada [4][5] - Green Thumb's focus on operational efficiency has helped maintain margins during downturns, with selective store openings reflecting a conservative growth strategy [5][6] - Financially, Green Thumb has shown resilience with steady revenue growth and improving profitability trends, supported by cost controls and operational discipline [6][8] Curaleaf Holdings (CURLF) - Curaleaf is one of the largest cannabis companies in the U.S., with a national footprint and operations in both medical and adult-use markets, enhancing revenue diversification [8][9] - The company operates over 100 dispensaries, with significant presence in Florida, New York, New Jersey, Illinois, Arizona, and Massachusetts, and controls multiple cultivation and processing facilities [9][11] - Curaleaf has several well-known brands, including Curaleaf, Select, and Grassroots, which strengthen its market penetration [11][12] - Financially, Curaleaf is among the highest-revenue operators, with recent restructuring efforts improving operational efficiency and focusing on profitability [12][13] Verano Holdings (VRNOF) - Verano has emerged as a major vertically integrated cannabis operator, with a strong retail focus and operations across multiple regulated markets [14][15] - The company operates more than 160 dispensaries, primarily in Florida, and has a diverse brand portfolio including MÜV, Zen Leaf, Savvy, and Encore [15][16] - Verano is focusing on operational improvements, with revenue growth supported by retail expansion and brand development, while prioritizing efficiency and margin stabilization [17][18] - The company's vertical integration offers advantages in cost control and product consistency, positioning it well for future growth in the evolving Florida market [18] Conclusion - As February 2026 approaches, the cannabis sector remains volatile but selective, with companies like Green Thumb, Curaleaf, and Verano standing out due to their scale, discipline, and strong brands [19]

Core Viewpoint - Green Thumb Industries Inc. is set to release its fourth quarter and full year 2025 financial results on February 25, 2026, after market close [1] Company Overview - Green Thumb Industries Inc. is a leading national cannabis consumer packaged goods company and retailer based in Chicago, Illinois [2] - The company manufactures and distributes a variety of licensed, branded cannabis products, including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon's, and Good Green [2] - Green Thumb operates RISE Dispensaries, a rapidly growing national retail chain, serving millions of patients and customers annually [2] - Established in 2014, Green Thumb has manufacturing facilities and retail stores across 14 U.S. markets, employing approximately 4,800 people [2]

Core Insights - The U.S. cannabis industry is nearing a significant inflection point, with ongoing federal policy discussions, particularly regarding cannabis rescheduling, which could lead to reduced tax burdens and improved profitability for operators [1][2] - Recent state-level expansions of adult-use programs and medical access frameworks, along with renewed federal banking reform discussions, are contributing to a growing momentum for legalization [2][6] - Companies with strong balance sheets and retail scale, such as Trulieve, Green Thumb Industries, and Cresco Labs, are well-positioned for growth as federal reforms progress [5][6] Industry Overview - The U.S. cannabis industry is evolving amidst regulatory uncertainty, with large multi-state operators focusing on long-term growth through scale, efficiency, and strong balance sheets [6][20] - Federal reform may be gradual, but even incremental changes could unlock significant value for cannabis companies [5][20] Company Profiles Trulieve Cannabis Corp. - Trulieve is one of the largest U.S. cannabis operators, with over 180 dispensaries, primarily in Florida, and a strong market share [9][10] - The company emphasizes cash flow stability, with steady revenue and strong gross margins, while maintaining disciplined capital expenditures and avoiding excessive dilution [12][10] Green Thumb Industries Inc. - Green Thumb operates over 100 dispensaries and focuses on branded consumer products, which differentiates it from competitors [13][14] - The company has maintained positive net income and strong operating cash flow, with a conservative balance sheet and manageable debt levels [15][14] Cresco Labs Inc. - Cresco is a vertically integrated operator with a strong wholesale focus, operating retail locations under the Sunnyside brand and maintaining a presence in key states [16][17] - The company has focused on stabilization and efficiency, with steady revenue and improving gross margins, while managing operating expenses carefully [19][18]

Core Insights - Green Thumb Industries reported third quarter revenue of $291 million, reflecting a 2% year-over-year increase, despite price compression in key markets [4][11] - The company achieved an adjusted EBITDA of $80 million, representing 28% of revenue, and cash flow from operations of $74 million [4][8] - The balance sheet remains strong with cash and cash equivalents totaling $226 million, and no senior credit facility maturities for four years [4][18] Financial Performance - Total revenue for Q3 2025 was $291.4 million, up 1.6% from the previous year [11] - Consumer Packaged Goods revenue increased by 8%, while retail revenue declined by 1% due to price compression in existing markets [11] - Gross profit was $144 million, or 49.4% of revenue, down from 51.4% in the prior year due to price compression [12] Share Repurchase and Capital Allocation - The company has repurchased approximately $107 million of subordinate voting shares since late 2023, reducing total shares outstanding by 13.5 million [5][19] - A new share repurchase program for $50 million was authorized, extending through September 2026 [5][19] Market Expansion and Strategy - The eighth Minnesota RISE Dispensary commenced adult-use sales on October 21, 2025, contributing to the company's growth strategy [3][10] - The company completed a transaction with RYTHM, Inc. to expand THC products beyond dispensaries, enhancing its market position [7] Industry Context - Despite ongoing challenges such as federal reform uncertainty and 280E taxation, cannabis demand continues to rise, positioning it as a fast-growing consumer category [6] - The company remains optimistic about future market share expansion and the establishment of adult-use markets in states like Virginia [11]

Core Viewpoint - Green Thumb Industries Inc. is set to release its third quarter 2025 financial results on November 5, 2025, after market close [1] Company Overview - Green Thumb Industries Inc. is a leading national cannabis consumer packaged goods company and retailer based in Chicago, Illinois [2] - The company manufactures and distributes a variety of branded cannabis products, including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon's, and Good Green [2] - Green Thumb operates RISE Dispensaries, a rapidly growing national retail chain, serving millions of patients and customers annually [2] - Established in 2014, the company has 20 manufacturing facilities and 108 retail stores across 14 U.S. markets, employing approximately 4,800 people [2]

Industry Overview - The U.S. cannabis industry generated over $33 billion in sales during 2024, making it one of the fastest-growing consumer sectors, with projections of annual sales surpassing $56 billion by 2030 [1] - Federal rescheduling efforts could ease tax burdens for cannabis companies, while more states are preparing adult-use legalization measures, increasing growth opportunities for multi-state operators [1][5] - The sector is characterized by volatility, necessitating careful evaluation of fundamentals and sector catalysts [1][12] Company Highlights Green Thumb Industries (OTC: GTBIF) - Green Thumb Industries operates over 100 dispensaries across 14 states, focusing on high-demand, limited-license markets, and has confirmed 108 locations with steady growth [3][5] - The company reported quarterly revenue of approximately $293 million in 2025, reflecting a year-over-year increase, with adjusted EBITDA around $83 million and operating cash flow of $56 million [4][5] - Green Thumb has a balance sheet with $177 million in cash, allowing for financial flexibility and continued investment [5] Glass House Brands (OTC: GLASF) - Glass House Brands focuses on California, managing 10 dispensaries and emphasizing large-scale greenhouse cultivation and efficient production [6][8] - The company reported second-quarter revenue of $59.9 million, an 11% year-over-year increase, with gross margins expanding to 53% and adjusted EBITDA of $18.1 million [8] - Cash reserves stood at $44.2 million, and cultivation volume reached 231,000 pounds during the quarter, with costs averaging $91 per pound [8] Cresco Labs (OTC: CRLBF) - Cresco Labs operates 71 Sunnyside dispensaries and focuses on both retail and wholesale, with significant brand development across various product categories [9][10] - The company posted revenue of $164 million in the second quarter of 2025, with an adjusted gross margin of 50.6% and adjusted EBITDA of approximately $41 million [11] - Cresco reported a net loss of $14 million, primarily from non-cash impairments, but has effectively controlled expenses, with selling, general, and administrative expenses at 31% of revenue [11] Investment Considerations - Investors are encouraged to apply technical analysis, monitoring support, resistance, and moving averages to improve timing in this volatile sector [12] - The upcoming catalysts, such as federal rescheduling and new state launches, make these three stocks—Green Thumb, Glass House, and Cresco—worth watching closely [12]

Core Viewpoint - Green Thumb Industries Inc. has authorized a $50 million share repurchase program to enhance shareholder value and maintain strategic flexibility in the expanding cannabis market [1][3]. Summary by Sections Share Repurchase Program - The program allows for the repurchase of up to 10,364,640 subordinate voting shares over the next 12 months [2]. - Previous repurchase efforts resulted in approximately 13.5 million shares being repurchased for $108 million since September 5, 2023 [2]. Management's Perspective - The CEO, Ben Kovler, emphasized that buying back stock at the right price is a key method for creating shareholder value and maintaining a strong market position [3]. - The new repurchase program will start on September 23, 2025, and end on September 22, 2026, with no obligation to purchase shares if better opportunities arise [3]. Financial Considerations - The company does not plan to incur debt to fund the share repurchase program, and the actual number of shares purchased will depend on market conditions [4]. - All repurchased shares will be returned to the treasury and canceled [4]. Company Overview - Green Thumb Industries is a leading national cannabis consumer packaged goods company, operating RISE Dispensaries and offering a range of branded products [5]. - Established in 2014, the company has 20 manufacturing facilities and 108 retail stores across 14 U.S. markets, employing approximately 4,800 people [5].

Industry Overview - The U.S. cannabis industry is experiencing significant growth, with legal sales surpassing $33 billion in 2024 and projected revenues of $50 billion by 2030 [1][3] - Expansion into new adult-use markets and growth in medical programs are creating new opportunities [1][3] - Federal rescheduling and potential banking reforms are increasing optimism in the sector [1][2] Key Companies - Trulieve Cannabis Corp. operates 231 retail dispensaries and has a strong presence in Florida, with a cultivation and processing footprint of over four million square feet [4][7] - Curaleaf Holdings, Inc. operates in 19 states with 154 retail dispensaries and has recently consolidated its international business, enhancing its global position [8][10] - Green Thumb Industries, Inc. operates over 101 retail locations and 20 manufacturing facilities, focusing on both adult-use and medical markets [12][14] Financial Performance - Trulieve reported $302 million in revenue for Q2 2025, with a gross margin of 61% and adjusted EBITDA of $111 million [7][15] - Curaleaf's Q2 2025 net revenue was $314.5 million, an 8% decline from the previous year, with a gross margin of 49% [10][11] - Green Thumb Industries reported Q2 2025 revenue of $293.3 million, a 4.7% increase year-over-year, with a gross margin of 49.9% [14][15] Market Positioning - Trulieve is recognized for its retail penetration and product distribution, supported by a large loyalty program with over 725,000 members [4][7] - Curaleaf's extensive retail and wholesale network positions it well for continued expansion, despite recent revenue challenges [8][11] - Green Thumb's strategy combines brand development with an expanding retail footprint, contributing to steady sales growth [12][14] Investment Considerations - The cannabis sector remains volatile, necessitating careful technical analysis and disciplined risk management for traders [1][2] - Companies with strong fundamentals and expanding footprints are likely to benefit from ongoing industry developments [2][15] - Investors are advised to monitor technical setups while applying risk management strategies to navigate the market effectively [16]